IHE — iShares U.S. Pharmaceuticals ETF price, holdings and performance

iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF (AMEX: IHE) is an exchange-traded fund. QuoTrend tracks its price, holdings, performance, fund flows and news.

Latest market price
101.53
-0.74-0.72%
OverviewShort InterestFilings
IHEiShares U.S. Pharmaceuticals ETF·AMEX
101.53-0.72%
TA
Loading chart...
Screen all →
VXUS-0.72%$85.88VUG+0.36%$88.75VTV-0.24%$221.25VO-0.19%$80.00VB-0.45%$289.61VWO+0.17%$60.01VGT+0.68%$122.31VIG-0.05%$237.00
Fund Snapshot
Category-Asset TypeEquityTagshealthcareReturn% 1Y45.46%Total Holdings54Perf Week0.46%
SponsorISharesETF TypeTagssectorReturn% 3Y19.05%AUM$1.62BPerf Month-6.13%
Fund FamilyBond TypeTags-Return% 5Y11.96%NAV/shPerf Quarter10.50%
Index-Average MaturityTags-Return% 10Y52W High108.66 -6.56%Perf Half Y19.35%
Index WeightingCommodity TypeTags-Return% SI52W Low69.02 47.10%Perf YTD19.69%
Active/PassiveQuant TypeTags-Flows% 1M0.00%Volatility1.08% 1.19%Perf Year44.46%
Dividend TTM1.43 (1.41%)ESG TypeTags-Flows% 3M48.87%ATR (14)1.52Perf 3Y60.07%
Dividend Ex-DateSep 15, 2026Dividend TypeSector/ThemeFlows% YTD78.36%RSI (14)44.05Perf 5Y60.32%
Dividend Gr. 3/5Y-Structure TypeRegionFlows% 1YBeta0.48Perf 10Y102.01%
Expense0.37%Growth/ValueSMA20-2.07%Flows% 3YRel Volume0.27Prev Close102.27
Inverse/LeveragedMarket CapSMA50-1.21%Flows% 5YAvg Volume268.75KPrice101.53
IPO DateApr 30, 2006Option/ShortYes / YesSMA20010.07%52W Range %82%Volume73,889Change-0.72%
Assets Under Management
00.40B0.80B1.20B1.60BFebMayJulSepNov'25MarMayJulSepNov'26MarMayJulSep
● Assets Under Management
Latest News· Times ET
Sep-15-26
Sep-15-2612:14PM
Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to BuyYahoo
03:20AM
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?zacks.com
Sep-11-26
Sep-11-2609:54AM
IHE: Innovation Supports The Outlook, Valuation Limits Convictionseekingalpha.com
Sep-10-26
Sep-10-2609:12AM
IHE: Large-Cap Pharma Cools After A Hot Summerseekingalpha.com
Sep-08-26
Sep-08-2610:59AM
Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund?fool.com
10:30AM
Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026?fool.com
Sep-03-26
Sep-03-2608:05AM
The Market May Be Telling Us We're Entering A Capital Formation CycleSeekingAlpha
Aug-24-26
Aug-24-2606:55AM
Where Is Growth?SeekingAlpha
Aug-21-26
Aug-21-2601:47PM
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset?fool.com
Aug-20-26
Aug-20-2601:14PM
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?fool.com
05:16AM
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy?fool.com
Aug-19-26
Aug-19-2605:10PM
Healthy And Energized At New HighsSeekingAlpha
Aug-14-26
Aug-14-2603:15AM
Fidelity Healthcare ETF vs. iShares Pharma Fund: Which Wins?fool.com
Aug-13-26
Aug-13-2611:38PM
iShares U.S. Pharmaceuticals ETF $IHE Shares Bought by Bank of America Corp DEdefenseworld.net
Aug-11-26
Aug-11-2608:30PM
Nearly A Third Of Tech Has Raised GuidanceSeekingAlpha
Fund

The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR